Literature DB >> 15330202

Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer.

Takashi Uno1, Koichi Isobe, Hiroyuki Kawakami, Naoyuki Ueno, Hiroki Kobayashi, Hideaki Shimada, Hisahiro Mastubara, Shinichi Okazumi, Yoshihiro Nabeya, Touru Shiratori, Takenori Ochiai, Tetsuya Kawata, Hisao Ito.   

Abstract

BACKGROUND: To evaluate the efficacy and toxicity of concurrent chemoradiation in patients with esophageal cancer aged 75 and older. PATIENTS AND METHODS: Twenty-two elderly patients were treated with concurrent chemoradiation. Seventeen received a combination of cisplatin/carboplatin and 5-fluorouracil, 5 received daily 5-fluorouracil. Total doses of radiotherapy ranged from 50 to 65 Gy.
RESULTS: Nineteen out of 22 patients completed the planned chemoradiation. Five in 8 patients (63%) with T1-2 lesion and 1 in 14 patients (7o%) with T3-4 lesion achieved complete response (p=0.011). Only 2 patients experienced grade 3 toxicities. Grade 2 or worse hematological toxicities were less frequently observed in patients who received local-field radiotherapy (p=0.006). There was no isolated lymph node recurrence. The median survival time was 9 months.
CONCLUSION: This study showed the potential for chemoradiation in elderly patients. A planning target volume of radiotherapy should include only clinically involved lesions in this setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330202

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Concurrent chemoradiation therapy tailored to the older adults with esophageal cancer: state of the art and the future.

Authors:  Tao Song; Min Fang; Shixiu Wu
Journal:  Clin Interv Aging       Date:  2018-11-08       Impact factor: 4.458

2.  Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation.

Authors:  Kai Ji; Lujun Zhao; Chengwen Yang; Maobin Meng; Ping Wang
Journal:  Radiat Oncol       Date:  2012-11-27       Impact factor: 3.481

3.  Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.

Authors:  Wang Jing; Hui Zhu; Hongbo Guo; Yan Zhang; Fang Shi; Anqin Han; Minghuan Li; Li Kong; Jinming Yu
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

4.  Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Xiaoli Zhang; Minghuan Li; Xue Meng; Li Kong; Yan Zhang; Guangsheng Wei; Xiqin Zhang; Fang Shi; Man Hu; Guoli Zhang; Jinming Yu
Journal:  Radiat Oncol       Date:  2014-02-26       Impact factor: 3.481

5.  Clinical results of proton beam therapy for twenty older patients with esophageal cancer.

Authors:  Takashi Ono; Tatsuya Nakamura; Yusuke Azami; Hisashi Yamaguchi; Yuichiro Hayashi; Motohisa Suzuki; Yoshiomi Hatayama; Iwao Tsukiyama; Masato Hareyama; Yasuhiro Kikuchi; Kenji Nemoto
Journal:  Radiol Oncol       Date:  2015-11-27       Impact factor: 2.991

Review 6.  Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.

Authors:  Minghuan Li; Xiaoli Zhang; Fen Zhao; Yijun Luo; Li Kong; Jinming Yu
Journal:  Radiat Oncol       Date:  2016-02-05       Impact factor: 3.481

7.  Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.

Authors:  Chunyue Huang; Yujia Zhu; Qiwen Li; Wenwen Zhang; Hui Liu; Weijun Zhang; Yonghong Hu; Yawei Yuan; Mengzhong Liu
Journal:  Cancer Med       Date:  2019-01-01       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.